Literature DB >> 17188079

Liver resection for benign liver tumors: indications and outcome.

Salleh Ibrahim1, Chao-Long Chen, Shih-Ho Wang, Chih-Che Lin, Chin-Hsiang Yang, Chee-Chien Yong, Bruno Jawan, Yu-Fan Cheng.   

Abstract

BACKGROUND: The indications for intervention in cases of benign liver tumors include symptoms, suspicion of malignancy, or risk of malignant change.
METHODS: Eighty-four liver resections for benign tumors were performed in our hospital from June 1996 to December 2004. The patient records were reviewed retrospectively.
RESULTS: The study group (41 females, 43 males; average age, 41.4 +/- 10.5 y) included 46 cavernous hemangiomas, 27 focal nodular hyperplasias, 5 hepatic adenomas, and 6 liver cysts. The indications for resection were inability to rule out malignancy (50 [59.5%]), symptoms (33 [39.3%]), and others (1 [1.2%]). Postoperatively, 28 of the 33 patients had resolution of symptoms. Twenty-nine patients (34.5%) had chronic hepatitis B infection.
CONCLUSIONS: Liver resection for benign liver tumor is safe, but indications for intervention must be evaluated carefully. The presence of chronic parenchymal liver disease does not increase morbidity in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17188079     DOI: 10.1016/j.amjsurg.2006.04.017

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

1.  Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database.

Authors:  Fabio Bagante; Gaya Spolverato; Steven M Strasberg; Faiz Gani; Vanessa Thompson; Bruce L Hall; David J Bentrem; Henry A Pitt; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-07-13       Impact factor: 3.452

Review 2.  Has laparoscopy increased surgical indications for benign tumors of the liver?

Authors:  Adriana Toro; Michel Gagner; Isidoro Di Carlo
Journal:  Langenbecks Arch Surg       Date:  2012-10-09       Impact factor: 3.445

3.  National trends in the use of surgery for benign hepatic tumors in the United States.

Authors:  Yuhree Kim; Neda Amini; Jin He; Georgios A Margonis; Matthew Weiss; Christopher L Wolfgang; Martin Makary; Kenzo Hirose; Gaya Spolverato; Timothy M Pawlik
Journal:  Surgery       Date:  2015-03-11       Impact factor: 3.982

4.  Early postoperative outcomes following hepatic resection for benign liver disease in 79 consecutive patients.

Authors:  Jeffrey T Lordan; Tim R Worthington; Nial Quiney; William Fawcett; Nariman D Karanjia
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

5.  Successful liver resection in a giant hemangioma with intestinal obstruction after embolization.

Authors:  Ji-Xiang Zhou; Ji-Wei Huang; Hong Wu; Yong Zeng
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

6.  Liver resection for benign hepatic lesions: a retrospective analysis of 827 consecutive cases.

Authors:  Zhi-Qiang Feng; Zhi-Qiang Huang; Li-Ning Xu; Rong Liu; Ai-Qun Zhang; Xiao-Qiang Huang; Wen-Zhi Zhang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

7.  Superextended hepatectomy for resection of multiple giant hemangiomas: report of a case.

Authors:  Silvia Pachera; Hideki Nishio; Hideki Yamada; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Masato Nagino
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

8.  [Incidentalomas of the liver and gallbladder. Evaluation and therapeutic procedure].

Authors:  Carl Zülke; H J Schlitt
Journal:  Chirurg       Date:  2007-08       Impact factor: 0.955

9.  Research on focal nodular hyperplasia with MSCT and postprocessing.

Authors:  Yuan-Jian Liu; Wei-Jun Fan; Zhi-Dong Yuan; Peng-Cheng Liu; Chun-Rong Wang; Wei-Qiang Yan; Su-Mei Wang; Jun-Hui Chen; Zheng Liu
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

10.  Impact on liver cancer treatment of a first erroneous diagnosis of hemangioma.

Authors:  Nazario Portolani; Gianluca Baiocchi; Federico Gheza; Sarah Molfino; Luigi Grazioli; Lucio Olivetti; Laura Romanini; Eleonora Frassi; Stefano Maria Giulini
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.